Eckert & Ziegler Strahlen- und Medizintechnik AG provided earnings guidance for the first half ended June 2019 and full year of 2019. According to initial analyses, revenues and earnings of the company as of June 30 were significantly higher than expected. While sales of EUR 81.0 million were generated in 2018 with continuing operations, this value is expected to have increased by 10% to EUR 89.0 million as of the half-year reporting date in 2019. In the same period, the earnings from continuing operations increased by 56% from EUR 1.65 to EUR 2.59 per share according to preliminary figures. The Executive Board expects that the consolidated result from continuing operations for fiscal year 2019 to exceed the forecast published at the beginning of the year. The previous target of EUR 3.50 is therefore increased to EUR 4.00 per share.